限制型心肌病的致病基因及诊治进展
[Abstract]:Restricted cardiomyopathy (Restrictive cardiomypathy,RCM) is a rare cardiomyopathy with poor prognosis and high risk of sudden death. Gene mutations that encode ganglion proteins, Z lines, cytoskeleton proteins, or intermediate filament networks have been identified to correlate with autosomal dominant RCM. This article reviews the recent advances in the research on the common mutated genes of RCM and their diagnosis and treatment.
【学位授予单位】:重庆医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R542.2
【参考文献】
相关期刊论文 前5条
1 Yan-ping Ruan;Chao-xia Lu;Xiao-yi Zhao;Rui-juan Liang;Hui Lian;Michael Routledge;Wei Wu;Xue Zhang;Zhong-jie Fan;;Restrictive Cardiomyopathy Resulting from a Troponin Ⅰ Type 3 Mutation in a Chinese Family[J];Chinese Medical Sciences Journal;2016年01期
2 Francesca Faita;Cecilia Vecoli;Ilenia Foffa;Maria Grazia Andreassi;;Next generation sequencing in cardiovascular diseases[J];World Journal of Cardiology;2012年10期
3 李东颖;任文君;;肌球蛋白结构和功能变化与运动的影响[J];中国组织工程研究与临床康复;2007年32期
4 Cecily E OAKLEY,Brett D HAMBLY,Paul MG CURMI,Louise J BROWN;Myosin binding protein C:Structural abnormalities in familial hypertrophic cardiomyopathy[J];Cell Research;2004年02期
5 杨世伟;陈彦;李军;殷杰;秦玉明;Gregor Andelfinger;汪道武;曹克将;;儿童原发性限制型心肌病三例的临床特征及遗传分析[J];中华心血管病杂志;2013年04期
,本文编号:2430074
本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2430074.html